We are live on ! Find out more
LAB icon

Standard BioTools
LAB

145 hedge funds and large institutions have $391M invested in Standard BioTools in 2020 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 54 increasing their positions, 32 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

101% more call options, than puts

Call options by funds: $5.23M | Put options by funds: $2.6M

69% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 32

41% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 27

8% more funds holding

Funds holding: 134 → 145 (+11)

4.66% less ownership

Funds ownership: 92.76% → 88.1% (-4.7%)

17% less capital invested

Capital invested by funds: $472M → $391M (-$80.9M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
145
Holders Change
+11
Holders Change %
+8.21%
% of All Funds
2.57%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
38
Increased
54
Reduced
32
Closed
27
Calls
$5.23M
Puts
$2.6M
Net Calls
+$2.63M
Net Calls Change
-$2.6M

Top Buyers

1
ICM
Indaba Capital Management
California
+$10.3M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$3.84M
3
ACM
Asymmetry Capital Management
California
+$3.72M
4
PCMI
Paradigm Capital Management Inc
New York
+$3.56M
5
Two Sigma Investments
Two Sigma Investments
New York
+$3.45M

Top Sellers

1
Invesco
Invesco
Georgia
-$13.8M
2
EP
Eversept Partners
New York
-$9.68M
3
Renaissance Technologies
Renaissance Technologies
New York
-$9.61M
4
Millennium Management
Millennium Management
New York
-$9.26M
5
PVI
Pura Vida Investments
New York
-$6.04M
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$705K +$99.8K +15,194 +15%
IP
52
Intellectus Partners
California
$701K +$246K +37,507 +47%
UBS AM
53
UBS AM
Illinois
$692K +$757K +115,300 New
HF
54
HRT Financial
New York
$685K +$751K +114,296 New
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$671K +$33.3K +5,066 +5%
AllianceBernstein
56
AllianceBernstein
Tennessee
$530K +$110K +16,800 +23%
OMC
57
Old Mission Capital
Illinois
$526K +$577K +87,762 New
CS
58
Credit Suisse
Switzerland
$513K +$562K +85,553 New
E
59
Ergoteles
New York
$500K +$548K +83,400 New
IA
60
IndexIQ Advisors
New York
$495K +$55.9K +8,514 +12%
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$483K +$405K +61,632 +326%
T. Rowe Price Associates
62
T. Rowe Price Associates
Maryland
$460K +$288K +43,800 +133%
PP
63
PDT Partners
New York
$452K -$932K -141,791 -65%
QT
64
Quantbot Technologies
New York
$408K +$447K +68,081 New
Squarepoint
65
Squarepoint
New York
$405K +$80.7K +12,277 +22%
Bank of America
66
Bank of America
North Carolina
$393K +$265K +40,290 +160%
QI
67
QS Investors
New York
$385K +$224K +34,100 +114%
ECM
68
ExodusPoint Capital Management
New York
$378K -$794K -120,824 -66%
Citadel Advisors
69
Citadel Advisors
Florida
$362K -$1.13M -172,535 -74%
Cambridge Investment Research Advisors
70
Cambridge Investment Research Advisors
Iowa
$338K +$156K +23,700 +73%
MCC
71
Money Concepts Capital
Florida
$332K +$364K +55,378 New
Deutsche Bank
72
Deutsche Bank
Germany
$313K +$58.5K +8,899 +21%
Invesco
73
Invesco
Georgia
$311K -$13.8M -2,102,751 -98%
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
$310K -$88.7K -13,500 -21%
TI
75
Trexquant Investment
Connecticut
$310K +$340K +51,680 New
1 2
3
4 5

LAB Hedge Fund Activity: Q4 2020 in Review

145 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2020, worth a combined $391M — down 17% from $472M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new LAB positions and 27 closed out — a net gain of 11 holders — while 54 added to existing stakes and 32 trimmed.

The largest buyer was Indaba Capital Management, adding an estimated $10.3M. The largest seller was Invesco, cutting an estimated $13.8M.

  • 145 institutional investors held Standard BioTools (LAB) as of Q4 2020, up from 134 in Q3 2020.
  • Funds reported $391M of Standard BioTools stock for Q4 2020, down 17% quarter-over-quarter.
  • 38 funds opened new Standard BioTools positions in Q4 2020 and 27 closed out, a net change of +11 holders.
  • The largest Standard BioTools buyer in Q4 2020 was Indaba Capital Management, an estimated $10.3M added.
  • The largest Standard BioTools seller in Q4 2020 was Invesco, an estimated $13.8M sold.

Based on aggregated 13F filings for Q4 2020.